Examples of using Dissolution test in English and their translations into Portuguese
{-}
-
Colloquial
-
Official
-
Medicine
-
Financial
-
Ecclesiastic
-
Ecclesiastic
-
Computer
-
Official/political
Medicine dissolution test meter.
The hplc method was developed, validated andsuccessfully applied in dissolution tests.
The dissolution test is the official method of evaluation of the in vitro drug performance.
In vitro drug release study was carried out by using modified dissolution test apparatus Fig.
In the dissolution test, eight samples presented unsatisfactory results in the first stage of the test, while the remainder presented inconclusive results.
In vitro drug release study was carried out by using modified dissolution test apparatus type 1 eight-station dissolution apparatus.
Reports of in vitro dissolution tests used for batch quality control and/or batch release should be placed in the Quality section(module 3) of the CTD.
In the development of the method it has been found that the duration of the dissolution test was 60 minutes, the volume and the medium more suitable dissolution we.
Dissolution test is important in development and production of drugs with application in quality control and previous step in bioequivalence studies.
An uv/visible spectrophotometric analytical method to determine the content of nimesulide in magistral capsules and a dissolution test for magistral capsules were satisfactorily validat.
The use of simulated intrinsic dissolution tests for pyrimethamine and metronidazole as a tool for biopharmaceutics classification is detailed in chapter 2.
Thus, it becomes necessary to perform the physical-chemical quality control of dosage forms containing lutein,develop and validate a dissolution test for tablets that carotenoid and assess their intestinal permeability.
Drug release is still frequently assessed by dissolution tests- a procedure, in which the tablet is placed in a solvent with similar properties to gastric acid.
This work proposed the development andvalidation of methods for quantitative analysis of rosuvastatin calcium(high performance liquid chromatography and spectrophotometry) and dissolution tests(also performed in biorelevant medium) for capsules and tablets forms.
The dissolution test on simvastatin tablets used apparatus 2 paddles, rotation of 50 rpm, temperature of 37°C, duration of 30 minutes and a sinker to avoid capsule floatation.
The influence of these factors may lead to low quantities of drug dissolved and determined in the dissolution test, thereby altering the amount absorbed and therefore the pharmacological activity level.
In the dissolution test, if the gelatin capsules float, they partially dissolve and this may lead to crosslinking and avoid the release of simvastatin into the dissolution medium.
The chemical adequacy test on the dissolver Erweka, model DT 800 was performed before carrying out the dissolution test, using calibrating tablets of prednisone and acetylsalicylic acid from the same pharmacopoeia.
The dissolution test determined the percentage of the active agent released into the dissolution medium, in relation to the value declared on the product label, within the period specified on the monograph.
The main objective of the present study was the evaluation of the stability of captopril 25 mg tablets in different primary packaging materials,once during stability studies it was observed a tendency to the second-stage dissolution test s2.
The quantity of simvastatin released in the dissolution test was determined as the difference between the absorbance readings at 247 and 257 nm, respectively, for the sample and standard.
Thus, the aim of this study was to develop and validate qualitative and quantitative analytical methods for both vlg and for the determination of drugs in association,to perform study of stability and dissolution tests using hplc and derivative uv spectrophotometric methods for this evaluation.
For this purpose, dissolution tests were performed using a synthetic carbonate rock by a modified oedometer cell, allowing a controlled flow of acidic solution through the pores o.
Polymeric systems s2 and s3 were characterized by morphological, spectroscopic and thermal analyses.the mechanism of in vitro release of ferulic acid was studied after dissolution test for systems s2 and s3. the release profiles were fitted by model-independent and model-dependent methods.
The present study aimed to develop and validate a stability indicating chromatographic method for quantitative analysis of ciprofibrate in commercial pharmaceutical forms,development of the dissolution test, to evaluate the drug stability under forced degradation, comprising the determination of the photodegradation kinetics and the study of drug cytotoxicity in the presence of the degradation products.
These inadequacies reflected problems in the ingredient mixing process and excipient and drug grain size variation, which altered the pharmacotechnicsof the formulations and affected the release of the active agent of the capsules in most of the dissolution test samples. The results suggest that the controls over the raw materials, compounding process and finished product quality were faulty or nonexistent in the pharmacies from which the formulations were dispensed.
Solid pharmaceutical forms tend to have problems related to bioavailability,making it necessary to perform the test of dissolution.